INGELHEIM, Germany - Monday, June 24th 2013 [ME NewsWire]

    Data show Pradaxa® is as effective as the standard of care while offering safety advantages in the treatment of acute and the prevention of recurrent DVT and PE1,2,3
    Pradaxa® is already approved for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation and for the primary prevention of venous thromboembolic events in patients undergoing elective total hip replacement or total knee replacement surgery4
    In-market experience with Pradaxa® already spans over 1.6 million patient-years in all currently licensed indications in over 100 countries worldwide5

(BUSINESS WIRE)-- For media outside of the U.S., the UK & Canada only

Boehringer Ingelheim today announced the submission of an application to the European Medicines Agency (EMA) for use of Pradaxa® (dabigatran etexilate) for the treatment ... Read more »

Funding supports global efforts to strengthen communities, promote well-being, and protect our environment

ATLANTA - Saturday, June 22nd 2013 [ME NewsWire]

(BUSINESS WIRE)-- The Coca-Cola Foundation -- the global philanthropic arm of The Coca-Cola Company -- awarded US$36 million in grants to 105 community organizations during the first quarter of 2013. The grants support the Foundation’s global priority areas and the Company’s three-part sustainability approach, focused on enhancing people’s well-being, building strong communities and protecting the environment.

"Coca-Cola wants to be a positive force in communities around the world,” said Lisa M. Borders, Chair of The Coca-Cola Foundation and Vice President of Global Community Connections for The Coca-Cola Company. "Through these grants, we have an amazing opportunity to make a real difference for millions of people by supporting personal well-being programs, improving access to critical natural resources such a ... Read more »